Trial Profile
Botox Drug Use Investigation (Spasmodic Dysphonia)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dysphonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 18 Jul 2019 Status changed from active, no longer recruiting to recruiting.
- 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.